Ownership history in PARK CIRCLE Co · 9 quarters on record
This page tracks every 13F SEC filing in which PARK CIRCLE Co reported a position in ARS PHARMACEUTICALS INC (SPRY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 2,000 | — | 0% | 0.02% | $20K | $10.05 |
| 2025 Q2 | UNCHANGED | 2,000 | — | 0% | 0.03% | $35K | $17.45 |
| 2025 Q1 | UNCHANGED | 2,000 | — | 0% | 0.02% | $25K | $12.58 |
| 2024 Q4 | UNCHANGED | 2,000 | — | 0% | 0.02% | $21K | $10.55 |
| 2024 Q3 | UNCHANGED | 2,000 | — | 0% | 0.03% | $29K | $14.50 |
| 2024 Q2 | UNCHANGED | 2,000 | — | 0% | 0.02% | $17K | $8.51 |
| 2024 Q1 | UNCHANGED | 2,000 | — | 0% | 0.02% | $20K | $10.22 |
| 2023 Q4 | UNCHANGED | 2,000 | — | 0% | 0.01% | $11K | $5.48 |
| 2023 Q3 | INITIATED | 2,000 | — | — | 0.01% | $8K | — |
As of 2025 Q4 — sorted by position size